Monoclonal Antibodies Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

CHAPTER 1. Industry Overview of Monoclonal Antibodies Market

1.1. Definition and Scope

1.1.1. Definition of Monoclonal Antibodies

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Monoclonal Antibodies Market

1.2. Summary

1.2.1. Executive Summary

1.2.2. Monoclonal Antibodies Market By Source Type

1.2.3. Monoclonal Antibodies Market By Production Method

1.2.4. Monoclonal Antibodies Market By Application

1.2.5. Monoclonal Antibodies Market By End-Use

1.2.6. Monoclonal Antibodies Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Monoclonal Antibodies Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Monoclonal Antibodies Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2022

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Monoclonal Antibodies Market By Source Type

4.1. Introduction

4.2. Monoclonal Antibodies Market Revenue By Source Type

4.2.1. Monoclonal Antibodies Market Revenue (USD Million) and Forecast, By Source Type, 2020-2032

4.2.2. Chimeric

4.2.2.1. Chimeric Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.3. Murine

4.2.3.1. Murine Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.4. Humanized

4.2.4.1. Humanized Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.5. Others

4.2.5.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 5. Monoclonal Antibodies Market By Production Method

5.1. Introduction

5.2. Monoclonal Antibodies Market Revenue By Production Method

5.2.1. Monoclonal Antibodies Market Revenue (USD Million) and Forecast, By Production Method, 2020-2032

5.2.2. In Vivo

5.2.2.1. In Vivo Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3. In Vitro

5.2.3.1. In Vitro Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 6. Monoclonal Antibodies Market By Application

6.1. Introduction

6.2. Monoclonal Antibodies Market Revenue By Application

6.2.1. Monoclonal Antibodies Market Revenue (USD Million) and Forecast, By Application, 2020-2032

6.2.2. Oncology

6.2.2.1. Oncology Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3. Autoimmune Diseases

6.2.3.1. Autoimmune Diseases Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.4. Infectious Diseases

6.2.4.1. Infectious Diseases Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.5. Neurological Diseases

6.2.5.1. Neurological Diseases Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.6. Others

6.2.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 7. Monoclonal Antibodies Market By End-Use

7.1. Introduction

7.2. Monoclonal Antibodies Market Revenue By End-Use

7.2.1. Monoclonal Antibodies Market Revenue (USD Million) and Forecast, By End-Use, 2020-2032

7.2.2. Hospitals

7.2.2.1. Hospitals Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.3. Specialty Centers

7.2.3.1. Specialty Centers Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.4. Others

7.2.4.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 8. North America Monoclonal Antibodies Market By Country 

8.1. North America Monoclonal Antibodies Market Overview

8.2. U.S.

8.2.1. U.S. Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Source Type, 2020-2032

8.2.2. U.S. Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Production Method, 2020-2032

8.2.3. U.S. Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Application, 2020-2032

8.2.4. U.S. Monoclonal Antibodies Market Revenue (USD Million) and Forecast By End-Use, 2020-2032

8.3. Canada

8.3.1. Canada Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Source Type, 2020-2032

8.3.2. Canada Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Production Method, 2020-2032

8.3.3. Canada Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Application, 2020-2032

8.3.4. Canada Monoclonal Antibodies Market Revenue (USD Million) and Forecast By End-Use, 2020-2032

8.4. North America PEST Analysis

CHAPTER 9. Europe Monoclonal Antibodies Market By Country

9.1. Europe Monoclonal Antibodies Market Overview

9.2. U.K.

9.2.1. U.K. Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Source Type, 2020-2032

9.2.2. U.K. Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Production Method, 2020-2032

9.2.3. U.K. Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Application, 2020-2032

9.2.4. U.K. Monoclonal Antibodies Market Revenue (USD Million) and Forecast By End-Use, 2020-2032

9.3. Germany

9.3.1. Germany Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Source Type, 2020-2032

9.3.2. Germany Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Production Method, 2020-2032

9.3.3. Germany Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Application, 2020-2032

9.3.4. Germany Monoclonal Antibodies Market Revenue (USD Million) and Forecast By End-Use, 2020-2032

9.4. France

9.4.1. France Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Source Type, 2020-2032

9.4.2. France Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Production Method, 2020-2032

9.4.3. France Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Application, 2020-2032

9.4.4. France Monoclonal Antibodies Market Revenue (USD Million) and Forecast By End-Use, 2020-2032

9.5. Spain

9.5.1. Spain Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Source Type, 2020-2032

9.5.2. Spain Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Production Method, 2020-2032

9.5.3. Spain Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Application, 2020-2032

9.5.4. Spain Monoclonal Antibodies Market Revenue (USD Million) and Forecast By End-Use, 2020-2032

9.6. Rest of Europe

9.6.1. Rest of Europe Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Source Type, 2020-2032

9.6.2. Rest of Europe Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Production Method, 2020-2032

9.6.3. Rest of Europe Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Application, 2020-2032

9.6.4. Rest of Europe Monoclonal Antibodies Market Revenue (USD Million) and Forecast By End-Use, 2020-2032

9.7. Europe PEST Analysis

CHAPTER 10. Asia Pacific Monoclonal Antibodies Market By Country

10.1. Asia Pacific Monoclonal Antibodies Market Overview

10.2. China

10.2.1. China Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Source Type, 2020-2032

10.2.2. China Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Production Method, 2020-2032

10.2.3. China Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Application, 2020-2032

10.2.4. China Monoclonal Antibodies Market Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.3. Japan

10.3.1. Japan Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Source Type, 2020-2032

10.3.2. Japan Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Production Method, 2020-2032

10.3.3. Japan Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Application, 2020-2032

10.3.4. Japan Monoclonal Antibodies Market Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.4. India

10.4.1. India Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Source Type, 2020-2032

10.4.2. India Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Production Method, 2020-2032

10.4.3. India Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Application, 2020-2032

10.4.4. India Monoclonal Antibodies Market Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.5. Australia

10.5.1. Australia Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Source Type, 2020-2032

10.5.2. Australia Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Production Method, 2020-2032

10.5.3. Australia Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Application, 2020-2032

10.5.4. Australia Monoclonal Antibodies Market Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.6. South Korea

10.6.1. South Korea Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Source Type, 2020-2032

10.6.2. South Korea Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Production Method, 2020-2032

10.6.3. South Korea Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Application, 2020-2032

10.6.4. South Korea Monoclonal Antibodies Market Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Source Type, 2020-2032

10.7.2. Rest of Asia-Pacific Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Production Method, 2020-2032

10.7.3. Rest of Asia-Pacific Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Application, 2020-2032

10.7.4. Rest of Asia-Pacific Monoclonal Antibodies Market Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Monoclonal Antibodies Market By Country

11.1. Latin America Monoclonal Antibodies Market Overview

11.2. Brazil

11.2.1. Brazil Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Source Type, 2020-2032

11.2.2. Brazil Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Production Method, 2020-2032

11.2.3. Brazil Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Application, 2020-2032

11.2.4. Brazil Monoclonal Antibodies Market Revenue (USD Million) and Forecast By End-Use, 2020-2032

11.3. Mexico

11.3.1. Mexico Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Source Type, 2020-2032

11.3.2. Mexico Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Production Method, 2020-2032

11.3.3. Mexico Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Application, 2020-2032

11.3.4. Mexico Monoclonal Antibodies Market Revenue (USD Million) and Forecast By End-Use, 2020-2032

11.4. Rest of Latin America

11.4.1. Rest of Latin America Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Source Type, 2020-2032

11.4.2. Rest of Latin America Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Production Method, 2020-2032

11.4.3. Rest of Latin America Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Application, 2020-2032

11.4.4. Rest of Latin America Monoclonal Antibodies Market Revenue (USD Million) and Forecast By End-Use, 2020-2032

11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Monoclonal Antibodies Market By Country 

12.1. Middle East & Africa Monoclonal Antibodies Market Overview

12.2. GCC

12.2.1. GCC Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Source Type, 2020-2032

12.2.2. GCC Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Production Method, 2020-2032

12.2.3. GCC Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Application, 2020-2032

12.2.4. GCC Monoclonal Antibodies Market Revenue (USD Million) and Forecast By End-Use, 2020-2032

12.3. South Africa

12.3.1. South Africa Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Source Type, 2020-2032

12.3.2. South Africa Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Production Method, 2020-2032

12.3.3. South Africa Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Application, 2020-2032

12.3.4. South Africa Monoclonal Antibodies Market Revenue (USD Million) and Forecast By End-Use, 2020-2032

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Source Type, 2020-2032

12.4.2. Rest of Middle East & Africa Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Production Method, 2020-2032

12.4.3. Rest of Middle East & Africa Monoclonal Antibodies Market Revenue (USD Million) and Forecast By Application, 2020-2032

12.4.4. Rest of Middle East & Africa Monoclonal Antibodies Market Revenue (USD Million) and Forecast By End-Use, 2020-2032

12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Monoclonal Antibodies Market

13.1. Monoclonal Antibodies Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Monoclonal Antibodies Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. Company Profile

14.1. Abbott Laboratories

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (USD Million), 2022

14.1.3.2. Abbott Laboratories 2022 Monoclonal Antibodies Business Regional Distribution

14.1.4. Product /Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. Amgen Inc.

14.3. AstraZeneca plc

14.4. Bayer AG

14.5. Biogen Inc.

14.6. Bristol Myers Squibb

14.7. Daiichi Sankyo Company Limited

14.8. Eli Lilly And Company

14.9. F. Hoffman-La Roche Ltd.

14.10. GlaxoSmithKline plc

14.11. Johnson & Johnson Services, Inc.

14.12. Merck & Co., Inc.

14.13. Novartis AG

14.14. Pfizer Inc.

14.15. Sanofi S.A.